Andrew Rut, chief executive of MyMeds&Me, a provider of adverse event and product quality capture software, considers in an Expert View piece how pharma’s abili 9 January 2018
In an area like oncology.innovation is needed not just with the end product.but in the way that researchers get there.finds Rik Van Mol.vice president of R&D st 15 November 2017
Bayer has entered into a strategic partnership with the healthcare division of Chinese tech company Alibaba Group, giving the German firm access to large amount 23 October 2017
When facing an illness, one of the first things that patients and caregivers do is go online for information, writes Dawn Lacallade, chief social strategist and 15 August 2017
Twenty-first century data is providing the data-heavy pharma industry with a modern dilemma: how to preserve corporate information when the speed of technologic 1 August 2017
A new report into the use of digital technology by the pharmaceutical industry details increased production of mobile apps, but stagnation in the growth of app 25 July 2017
The growing number of clinical trials and increasing complexity across the clinical lifecycle are putting pressure on life sciences organizations to improve stu 4 July 2017
The interim president and chief executive of Teva Pharmaceutical, Yitzhak Peterburg, has said that he believes the healthcare industry is undergoing “huge disru 29 June 2017
Todd Greenwood.director of digital Strategy at digital health specialists Medullan.provides an expert view on the value of real-world evidence and patient suppo 26 June 2017
The dramatic availability of new data sources along with the opportunity to leverage existing data pools.is radically changing the way we think about clinical t 14 June 2017
In this week's Expert View.Gijs Hubben considers the role of value communication in facilitating market access for new pharmaceuticals.distilling his experience 17 April 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.